Legenda
Dr. Alessandra Bigi graduated with highest marks et encomium in Biology at the University of Florence in 2016. She obtained the PhD in Biomedical Sciences at the Department of Experimental and Clinical Biomedical Sciences, University of Florence, in 2020. During the PhD her research activities concerned the relationship between structure and toxicity of aberrant protein aggregates in protein deposition diseases such as Alzheimer’s disease (AD), Parkinson’s Disease (PD) and amyotrophic lateral sclerosis (ALS). She has been Postdoctoral Research fellow (Assegnista di Ricerca) at the Department of Experimental and Clinical Biomedical Sciences, University of Florence, from 2020 to 2023. In this period, she has been involved in several research projects focused on the study of the cytotoxic pathways associated with protein misfolded diseases, with the aim to identify novel diagnostic and therapeutic approaches against age-associated pathologies. Today she is a Researcher (RTD-A) in Biochemistry (SSD BIO/10).She has 23 international publications (JCR) and her h index (Scopus) is 11. She is a member of the Italian Society of Biochemistry and Molecular Biology (SIB) since 2017.
Education and training
April 2020
PhD in “Biomedical Sciences”, curriculum “Functional Biology of Biomolecules and Biosystems” with a thesis entitled “Study of the relationship between structure and toxicity of different α-synuclein aggregates and related cellular dysfunctions”. Supervisor Prof. Cristina Cecchi.
Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy.
July 2016
Master’s Degree in Biology (LM-6). Final mark: 110/110 cum laude and Complimenti della Commissione
University of Florence, Italy.
April 2013
Bachelor’s Degree in Biological Sciences (L-13). Final mark: 110/110
July 2009
Scientific High School Diploma. Final mark: 100/100
Liceo Scientifico Francesco Redi, Arezzo, Italy.
Research experience
01/02/2023 - Present
Researcher (RTD-A) in Biochemistry (SSD BIO/10), at the Department of Experimental and Clinical Biomedical Sciences, University of Florence.
01/03/2022 - 31/01/2023
Postdoctoral Research Fellow at the Department of Experimental and Clinical Biomedical Sciences, University of Florence.
Research Project: “Trodusquemine as a new therapeutic molecule for amyotrophic lateral sclerosis”. Supervisor Prof. Cristina Cecchi.
01/03/2021 –28/02/2022
Research Project: “Single domain antibodies as diagnostic and therapeutic tools for Alzheimer's disease”. Supervisor Dr. Roberta Cascella.
01/03/2020 – 28/02/2021
Research Project: “Functional characterization of full-lenght TDP-43 in the pathogenesis of amyotrophic lateral sclerosis”. Supervisors Prof. Cristina Cecchi and Prof. Fabrizio Chiti.
01/11/2016 - 31/10/2019
PhD student in “Biomedical Sciences” at the Department of Experimental and Clinical Biomedical Sciences, University of Florence. Supervisor Prof. Cristina Cecchi.
Professional Membership
2017 - Present
Member of the Italian Society of Biochemistry and Molecular Biology (SIB).
Honours
FEBS Open Bio Poster Prize at the 48th FEBS Congress “Mining Biochemistry for Human Health and Well-Being”, Milano (Italy), June 29th - July 3rd, 2024.
2021
Poster Prize at the “SIB 2021 61° Congress” (entirely virtual), September, 23-24, 2021, for presenting the abstract “Diagnostic and therapeutic potential of single-domain antibodies in Alzheimer’s disease”.
Selected speaker at national and international conferences
2024
2022
Bigi A, Cascella R, Ermini E, Barbut D, Zasloff M, Chiti F, Cecchi C. “Mechanisticinsights into the protective role of trodusquemine in TDP-43-associated proteinopathies”. TUM Congress 2022, Perugia (Italy), December 1st, 2022.
Bigi A, Cascella R, Lombardo E, Barbut D, Zasloff M, Chiti F, Cecchi C. “Trodusquemine prevents TDP-43 inclusion formation and suppresses its toxicity in vitro and in vivo”. Oral “on demand” uploaded in the virtual Conference platform of the “Hybrid AD/PD™ 2022, Alzheimer’s & Parkinson’s Diseases Conference” – Barcelona (Spain), March 15-20, 2022.
Bigi A, Napolitano L. Vadukul D, Aprile FA, Chiti F, Cecchi C, Cascella R. “Diagnostic and therapeutic potential of single domain antibodies in Alzheimer’s disease”. “SIB 2021 61° Congress” (entirely virtual) September 23-24, 2021 (poster and short oral presentation).
2019
Bigi A, Cascella R, Chen SW, De Simone A, Dobson CM, Chiti F, Cecchi C. Molecular basis of neuronal calcium dyshomeostasis caused by α-synuclein aggregates in Parkinson’s disease. “SIB 2019 60° Congress” Lecce (Italy), September 18-20, 2019 (poster and short oral presentation).
2017
Bigi A, Evangelisti E, Stefani M, Chiti F, Cecchi C, Cascella R. Aβ42 oligomers interact with GM1 ganglioside inducing neuronal calcium overload. “SIB 2019 59° Congress” Caserta (Italy), September 20-22, 2017.
Other scientific activities
Since 2019
Reviewer for Neural Regeneration Research, Biomedicines, Cellular and Molecular Life Sciences, Cells, International Journal of Molecular Sciences, Pharmaceutics, Review Commons, Scientific Reports, Pharmaceuticals, Neurochemistry International, BBA - Molecular Cell Research.